Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives | |
He, Ni-Ya; Li, Qing; Wu, Chun-Yan; Ren, Zhong; Gao, Ya; Pan, Li-Hong; Wang, Mei-Mei; Wen, Hong-Yan(文红艳); Jiang, Zhi-Sheng; Tang, Zhi-Han* | |
刊名 | Acta Pharmacologica Sinica
![]() |
2017 | |
卷号 | 38期号:3页码:301-311 |
关键词 | PCSK9 LDL receptor monoclonal antibodies anti-sense oligonucleotide mimetic peptides adnectin CRISPR/Cas9 platform berberine oleanollc acid neuronal apoptosis coronary artery disease cholesterol metabolism |
ISSN号 | 1671-4083 |
DOI | 10.1038/aps.2016.134 |
URL标识 | 查看原文 |
WOS记录号 | WOS:000395792800001;PMID:28112180 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5706665 |
专题 | 湖南中医药大学 |
作者单位 | 1.[Gao, Ya 2.Jiang, Zhi-Sheng 3.Ren, Zhong 4.Li, Qing 5.Tang, Zhi-Han 6.Tang, ZH 7.Liu, Lu-Shan 8.He, Ni-Ya 9.Wang, Mei-Mei 10.Wu, Chun-Yan |
推荐引用方式 GB/T 7714 | He, Ni-Ya,Li, Qing,Wu, Chun-Yan,et al. Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives[J]. Acta Pharmacologica Sinica,2017,38(3):301-311. |
APA | He, Ni-Ya.,Li, Qing.,Wu, Chun-Yan.,Ren, Zhong.,Gao, Ya.,...&Liu, Lu-Shan*.(2017).Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives.Acta Pharmacologica Sinica,38(3),301-311. |
MLA | He, Ni-Ya,et al."Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives".Acta Pharmacologica Sinica 38.3(2017):301-311. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论